New Key Statistics Module, Z-Score and F-Score
OTCPK:BIOVF Key Ratios
Market Cap $ M | 10,194.37 |
Enterprise Value $ M | 12,000.03 |
P/E(ttm) | 31.90 |
PE Ratio without NRI | 29.99 |
Forward PE Ratio | 21.16 |
Price/Book | 3.01 |
Price/Sales | 4.46 |
Price/Free Cash Flow | 32.83 |
Price/Owner Earnings | 32.31 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,460.00 |
EPS (TTM) $ | 0.99 |
Beneish M-Score | -2.49 |
10-y EBITDA Growth Rate % | 41.70 |
5-y EBITDA Growth Rate % | 7.60 |
y-y EBITDA Growth Rate % | 18.30 |
EV-to-EBIT | 23.15 |
EV-to-EBITDA | 13.94 |
PEG | 3.95 |
Shares Outstanding M | 343.44 |
Net Margin (%) | 13.82 |
Operating Margin % | 22.37 |
Pre-tax Margin (%) | 16.54 |
Quick Ratio | 0.62 |
Current Ratio | 0.91 |
ROA % (ttm) | 4.76 |
ROE % (ttm) | 9.89 |
ROIC % (ttm) | 6.19 |
Dividend Yield % | -- |
Altman Z-Score | 2.90 |
BIOVF Number of Guru Trades
BIOVF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BIOVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BIOVF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Swedish Orphan Biovitrum AB Insider Transactions
No Available Data
News about OTCPK:BIOVF
Total 0- 1